NCT01272986已完成3 期
Trial of Screening for ALOA-IgG AtheroAbzyme Test Comparing Healthy,Asymptomatic Myocardial Ischemic and Acute Coronary Syndrome Patients
Omicron Pharmaceuticals1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2011年1月1日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
- 试验地点
- 1
- 主要终点
- Measuring the degree of oxidized low-density lipoprotein (LDL) by ALOA- IgG AtheroAbzyme in healthy and cardiovascular disease patients
研究概览
简要总结
This is a trial of screening for ALOA-IgG AtheroAbzyme Test comparing healthy, asymptomatic myocardial ischemic and acute coronary syndrome patients.
研究设计
- 研究类型
- Interventional
- 分配方式
- Non Randomized
- 干预模型
- Parallel
- 主要目的
- Diagnostic
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 是
入选标准
- •Healthy patients
- •High Risk patients or Asymptomatic myocardial Ischemic patients
- •Acute Coronary Syndrome patients
排除标准
- 未提供
结局指标
主要结局
Measuring the degree of oxidized low-density lipoprotein (LDL) by ALOA- IgG AtheroAbzyme in healthy and cardiovascular disease patients
时间窗: Three months
次要结局
未报告次要终点
研究者
研究点 (1)
Loading locations...
相似试验
已完成
不适用
Cardiac Amyloidosis Screening at Trigger Finger ReleaseTrigger FingerTransthyretin AmyloidosisPrimary Amyloidosis of Light Chain TypeAmyloidosisNCT03886155The Cleveland Clinic107
已完成
不适用
Early Detection of Myocardial Ischaemia in Suspected Acute Coronary Syndromes by Apo J-GlycMyocardial IschemiaNCT04119882Glycardial Diagnostics S.L.404
已完成
不适用
A Diagnostic Screening Trial Seeking AL Amyloidosis Very EarlyPlasma Cell DyscrasiaMonoclonal GammopathyNCT02741999Tufts Medical Center20
已完成
不适用
Cardiac Amyloidosis Discovery TrialCardiac AmyloidosisNCT06469372Pierre Elias50
尚未招募
Unknown
Screening for cardiac amyloidosis in patients with newly identified conduction diseaseCardiac amylodiosisCardiovascular - Other cardiovascular diseasesACTRN12624000520538Box Hill Hospital220